British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
Effectiveness of the National Health Screening Program for Infants and Children in Detecting Neurodevelopmental Disorders: A Nationwide Population-Based Analysis. [PDF]
Ann Rehabil MedKim SW, Yoo NY, Kim Y, Youk T, Hong S.
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
British Journal of Clinical Pharmacology, EarlyView.Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
A Legal and Policy Analysis of Driver\u27s Licenses for Undocumented Rhode Islanders [PDF]
, 2017 Gonzalez, Deborah, Margulies, Peter
core +1 more source
Multidimensional predictors of fatigue in amyotrophic lateral sclerosis: a cross-sectional study in China. [PDF]
Sci RepCai F +8 more
europepmc +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić +4 more
wiley +1 more source
The Pricing Effects of European Union Insurance Liberalization on Italian Motor Insurance [PDF]
, 2006 Heikes, Andy, Park, Faculty Advisor, Jin
core +1 more source
Re: Comments on "Potentially Inappropriate Medication Use in Patients With Parkinson's Disease: Analysis of Korean National Health Insurance Claims Data". [PDF]
J Clin NeurolJung YJ, Shin J, Kwon DY, Lee SM.
europepmc +1 more source
Rates of fall injuries across three claims databases, 2019. [PDF]
Inj PrevMiller GF +6 more
europepmc +1 more source